HANALL BIOPHARMA revenue for the last year amounted to 137.00 B KRW, the most of which — 134.91 B KRW — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 110.00 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought HANALL BIOPHARMA 134.84 B KRW, and the year before that — 109.96 B KRW.